INTERNATIONAL PATENT: SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES FILES APPLICATION FOR "AN ISOINDOL-SULFILIMINE COMPOUND AND USE AS A SIGMA-2 RECEPTOR INHIBITOR THEREOF"

GENEVA, March 24 -- SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES (Zhouzhu Road No. 279Pudong New Area, Shanghai 201318) filed a patent application (PCT/CN2024/106052) for "AN ISOINDOL-SULFILIMINE COMPOUND AND USE AS A SIGMA-2 RECEPTOR INHIBITOR THEREOF" on Jul 17, 2024. With publication no. WO/2025/055549, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LU, Xiuhong (Zhouzhu Road No. 279Pudong New Area, Shanghai 201318), HUANG, Gang (Zhouzhu Road No. 279Pudong New Area, Shanghai 201318), SUN, Anyang (Zhouzhu Road No...